US 6,784,206 B2 · Corosolic acid formulation and its application for weight-loss management and blood sugar balance

Abstract

A soft gelatin capsule and method to deliver an efficable dose of Lagerstroemia speciosa L. (marketed by Soft Gel Technologies under the trademark Glucosol™) for the assistance and maintenance of moderate weight loss through blood sugar maintenance. The product relies on the effects of corosolic acid on blood sugar levels to derive a healthy weight loss effect for Type II diabetics (non-insulin dependent) and healthy non-diabetics and the improved absorption of an oil based delivery system. The product provides safe and sustainable weight loss when combined with a restricted calorie diet and regular exercise. Its benefits include improvement of cardiovascular health, normalized blood sugar levels, and improved physical appearance with the positive psychological effects associated with successful and safe weight loss/maintenance.

Claims1

Dependent claims

A method for manufacture of a soft gel capsule for absorption of Corosolic acid into the intestinal tract of a human in order to maintain blood sugar levels and facilitate weight-loss in the human including:

heating rice brain oil to about 35° C. in a container,
adding a filler such as yellow bee's wax or silica, and
adding 1% Corosolic acid under a vacuum in order to form a mixture;
continuously stirring the mixture;
cooling the mixture to room temperature;
nitrogen gas blanketing the container;
and
encapsulating the mixture into a soft gel capsule.

5 more elements

Dependencies are inferred from the claim text.

Facts

Application

10/640,886Filed 14 Aug 2003 · division

Priority

5 Apr 2000

Published

US 2004/0072901 A115 Apr 2004

Granted

31 Aug 2004

Term ends

Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 9/4825
Wall or shell material: proteins, e.g. gelatin
A61K 9/485
Filling excipients; Inactive ingredients: inorganic compounds
A61K 9/4858
Filling excipients; Inactive ingredients: organic compounds
A61K 31/19
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids: carboxylic acids, e.g. valproic acid

Family

Application60/194,913Us provisional application · filed 5 Apr 2000

Application09/825,920Parent of this division · filed 3 Apr 2001

US 2004/0072901 A1Pre-grant publication · published 15 Apr 2004

US 7,713,546 B1Related patent

US 6,784,206 B2This patent

From the US filing history. Foreign family members aren’t listed.

Corosolic acid formulation and its application for weight-loss management and blood sugar balance

Life of this patent

Corosolic acid formulation and its application for weight-loss management and blood sugar balance

Life of this patent

Abstract

Claims1